Skip to content

Welcome to Discover Pharma! Today is : October 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

protein engineering

  • Drug Discovery & Development,Research & Development

    Anthropic AI protein designs undergo large-scale experimental validation

    Anthropic’s Claude AI models generated protein binders against 15 targets, [...]

    August 24, 2026
  • Digital & Data,Drug Delivery & Formulation,Research & Development

    AI-driven antibody discovery could create $7bn market for life science tools

    AI-driven antibody discovery could create a $7 billion market opportunity [...]

    July 27, 2026
  • Advanced Therapies,Drug Discovery & Development

    Molecular Devices unveils automated QPix FLEX system to transform microbial colony picking

    New benchtop platform boosts speed, sterility, and accuracy for microbiology [...]

    May 5, 2026
  • Advanced Therapies

    Cycuria Therapeutics launches with advisory board and major grant funding

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Novadip secures €10.4M to advance pivotal Phase 3 trial
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Research & Development, Therapeutic Areas
  • Telix to acquire ITM in $1.65BN radiopharmaceutical deal
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Andelyn to manufacture FDA-approved Fayuvi gene therapy for Sanfilippo syndrome
    Categories: Advanced Therapies, Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top